22NW Fund, L.P. v. Lifecore Biomedical, Inc.

2025 NY Slip Op 31653(U)
CourtNew York Supreme Court, New York County
DecidedMay 5, 2025
DocketIndex No. 659802/2024
StatusUnpublished

This text of 2025 NY Slip Op 31653(U) (22NW Fund, L.P. v. Lifecore Biomedical, Inc.) is published on Counsel Stack Legal Research, covering New York Supreme Court, New York County primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
22NW Fund, L.P. v. Lifecore Biomedical, Inc., 2025 NY Slip Op 31653(U) (N.Y. Super. Ct. 2025).

Opinion

22NW Fund, L.P. v Lifecore Biomedical, Inc. 2025 NY Slip Op 31653(U) May 5, 2025 Supreme Court, New York County Docket Number: Index No. 659802/2024 Judge: Nancy M. Bannon Cases posted with a "30000" identifier, i.e., 2013 NY Slip Op 30001(U), are republished from various New York State and local government sources, including the New York State Unified Court System's eCourts Service. This opinion is uncorrected and not selected for official publication. INDEX NO. 659802/2024 NYSCEF DOC. NO. 117 RECEIVED NYSCEF: 05/05/2025

SUPREME COURT OF THE STATE OF NEW YORK NEW YORK COUNTY PRESENT: HON. NANCY M. BANNON PART 61M Justice ---------------------------------------------------------------------------------X INDEX NO. 659802/2024 22NW FUND, L.P., MOTION DATE 05/02/2025 Plaintiff, MOTION SEQ. NO. 005 -v- LIFECORE BIOMEDICAL, INC.,JAMES G. HALL, JOHN MORBERG, KATRINA L. HOUDE, JEFFREY L. EDWARDS, DECISION + ORDER ON JOSHUA E. SCHECHTER, CRAIG BARBAROSH, RAYMOND DIRADORRIAN MOTION

Defendants. ---------------------------------------------------------------------------------X

The following e-filed documents, listed by NYSCEF document number (Motion 005) 94, 95, 96, 97, 100, 101, 109, 110, 111, 112, 113, 114 were read on this motion to/for SEAL .

In this breach of contract action, the defendants move by order to show cause pursuant to 22 NYCRR 216.1(a), to seal certain unredacted versions of exhibits filed in support of the defendants’ motions to dismiss (NYSCEF Doc. Nos. 44, 49, 51, 61, 63, 66, 68, 71, 73, 76, 78, 81, 83, 86, 88, 91, and 93). By order dated April 4, 2025, the court granted the defendants’ requests for TROs to maintain the subject documents under seal pending decision on the present motion. The plaintiff opposes only the branch of the defendant’s motion seeking to maintain the documents at NYSCEF Doc. Nos. 44, 49, and 51 under seal. By letter dated April 3, 2025, the defendants represented that they did not object to allowing the TRO to expire as to NYSCEF Doc. Nos. 44, 49, and 51. The remaining branch of the defendants’ motion to seal NYSCEF Doc. Nos. 44, 49, 51, 61, 63, 66, 68, 71, 73, 76, 78, 81, 83, 86, 88, 91, and 93, is granted.

22 NYCRR 216.1(a) provides that “a court shall not enter an order in any action or proceeding sealing the court records, whether in whole or in part, except upon a written finding of good cause, which shall specify the grounds thereof. In determining whether good cause has been shown, the court shall consider the interests of the public as well as of the parties.”

659802/2024 22NW FUND, L.P. vs. LIFECORE BIOMEDICAL, INC. ET AL Page 1 of 4 Motion No. 005

1 of 4 [* 1] INDEX NO. 659802/2024 NYSCEF DOC. NO. 117 RECEIVED NYSCEF: 05/05/2025

“[P]ublic access to court proceedings is strongly favored, both as a matter of constitutional law (Richmond Newspapers v Virginia, 448 U.S. 555 [1980]) and as a statutory imperative (Judiciary Law § 4).” Anonymous v Anonymous, 158 AD2d 296, 297 (1st Dept. 1990); see also Herald Co. v Weisenberg, 59 NY2d 378 (1983) (closure of courtroom). Moreover, “the public interest in openness is particularly important on matters of public concern, even if the issues arise in the context of a private dispute.” Danco Labs., Ltd. v Chemical Works of Gedeon Richter, Ltd., 274 AD2d 1, 7 (1st Dept. 2000). Accordingly, the Appellate Division, First Department, has emphasized that “there is a broad presumption that the public is entitled to access to judicial proceedings and court records.” Mosallem v Berenson, 76 AD3d 345, 348 (1st Dept. 2010). Because “confidentiality is clearly the exception, not the rule” (Matter of Hofmann, 284 AD2d 92, 93–94 [1st Dept. 2001]), that Court has authorized sealing “only in strictly limited circumstances” (Gryphon Dom. VI, LLC v APP Intl. Fin. Co., 28 AD3d 322, 325 [1st Dept. 2006]; see Mosallem v Berenson, supra).

As stated, in any application to seal court records, the burden is on the party seeking sealing to establish “good cause.” 22 NYCRR 216.1(a). “Since there is no absolute definition, a finding of good cause, in essence, ‘boils down to … the prudent exercise of the court’s discretion.’” Applehead Pictures, LLC v Perelman, 80 AD3d 181, 192 (1st Dept. 2010), quoting Mancheski v Gabelli Group Capital Partners, 39 AD3d 499, 502 (2nd Dept. 2007) (some internal quotation marks and citation omitted).

Furthermore “[a] finding of ‘good cause’ presupposes that ... no alternative to sealing can adequately protect the threatened interest.” Mancheski v Gabelli Group Capital Partners, 39 AD3d 499, 502 (2nd Dept. 2007) citing In re Herald Co., 734 F2d 93, 100 [2nd Cir. 1984]). Appropriate less restrictive alternative relief may and should be granted to balance the competing interests of public access and the need for secrecy or confidentiality. See Danco Labs v Chem. Works of Gedeon Richter, 274 AD2d 1 (1st Dept. 2000). It is well settled that redaction can be such an appropriate alternative relief. See Id.; Jose V. v Smiley & Smiley LLP, 214 AD3d 523 (1st Dept. 2023); Gliklad v Derispaska, 185 AD3d 512 (1st Dept. 2020); Maxim, Inc. v Feifer, 145 AD3d 516 (1st Dept. 2016).

The defendants seek to permanently seal exhibits attached to the individual affirmations filed by defendants James G. Hall, John Morberg, Katrina L. Houde, Jeffrey Edwards, Joshua Schechter, Craig Barbarosh, and Raymond Diradorrian (collectively, the “Individual

659802/2024 22NW FUND, L.P. vs. LIFECORE BIOMEDICAL, INC. ET AL Page 2 of 4 Motion No. 005

2 of 4 [* 2] INDEX NO. 659802/2024 NYSCEF DOC. NO. 117 RECEIVED NYSCEF: 05/05/2025

Defendants”), in support of their motion to dismiss the complaint (MOT SEQ 004). Specifically, these exhibits include each of the Individual Defendant’s driver’s licenses (NYSCEF Doc. Nos. 61, 66, 71, 76, 81, 86, and 91), and a utility bill of each Individual Defendant (NYSCEF Doc. Nos. 63, 68, 73, 78, 83, 88, 93). These exhibits include the Individual Defendant’s personal information, including their home addresses and identification numbers for their driver’s licenses and utility bills.

The court finds that there is good cause for these redactions to prevent the disclosure of sensitive personal information. See Randall Co. LLC v 281 Broadway Holdings LLC, 132 AD3d 452 (1st Dept. 2015); Soiefer v Soiefer, 17 AD3d 268 (1st Dept. 2005); Fochetta v Schlackman, 257 AD2d 546 (1st Dept. 1999). The defendants’ claims of the need for confidentiality are not conclusory. The defendants have also filed redacted copies of the same utility bills (NYSCEF Doc. Nos. 60, 65, 70, 75, 80, 85, and 90) and driver’s licenses (NYSCEF Doc. Nos. 62, 67, 72, 77, 82, 87, and 92) in support of MOT SEQ 004. Comparison of the redacted and unredacted versions show that the defendants’ redactions are narrowly tailored to avoid disclosure of sensitive personal identifying information such as driver’s license numbers and personal addresses, as required by court rules to be redacted prior to submission to the court pursuant to 22 NYCRR 202.5(e). The defendants also seek an order to seal future submissions containing or referencing the redacted portions of the above exhibits in any public filings with the court. This relief is also granted. Future submissions containing or referencing the above exhibits in any public filings with the court shall likewise be redacted to remove the Individual Defendant’s personal information, including identification numbers and home addresses in compliance with 22 NYCRR 202.5(e).

Accordingly, it is

ORDERED that the plaintiff’s motion to seal is granted, upon a finding of “good cause”, as to NYSCEF Doc. Nos. 61, 63, 66, 68, 71, 73, 76, 78, 81, 83, 86, 88, 91, and 93, and it is further,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Richmond Newspapers, Inc. v. Virginia
448 U.S. 555 (Supreme Court, 1980)
Randall Co. LLC v. 281 Broadway Holdings LLC
132 A.D.3d 452 (Appellate Division of the Supreme Court of New York, 2015)
Maxim Inc. v. Feifer
2016 NY Slip Op 8319 (Appellate Division of the Supreme Court of New York, 2016)
Matter of Gliklad v. Deripaska
2020 NY Slip Op 4233 (Appellate Division of the Supreme Court of New York, 2020)
Herald Co. v. Weisenberg
452 N.E.2d 1190 (New York Court of Appeals, 1983)
Soiefer v. Soiefer
17 A.D.3d 268 (Appellate Division of the Supreme Court of New York, 2005)
Gryphon Domestic VI, LLC v. APP International Finance Co.
28 A.D.3d 322 (Appellate Division of the Supreme Court of New York, 2006)
Mancheski v. Gabelli Group Capital Partners
39 A.D.3d 499 (Appellate Division of the Supreme Court of New York, 2007)
Applehead Pictures LLC v. Perelman
80 A.D.3d 181 (Appellate Division of the Supreme Court of New York, 2010)
Anonymous v. Anonymous
158 A.D.2d 296 (Appellate Division of the Supreme Court of New York, 1990)
Fochetta v. Schlackman
257 A.D.2d 546 (Appellate Division of the Supreme Court of New York, 1999)
Danco Laboratories, Ltd. v. Chemical Works of Gedeon Richter, Ltd.
274 A.D.2d 1 (Appellate Division of the Supreme Court of New York, 2000)
In re the Estate of Hofmann
284 A.D.2d 92 (Appellate Division of the Supreme Court of New York, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
2025 NY Slip Op 31653(U), Counsel Stack Legal Research, https://law.counselstack.com/opinion/22nw-fund-lp-v-lifecore-biomedical-inc-nysupctnewyork-2025.